Mainolfi Nello Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
26
Insider Sells Sum
$26.16M

Insider Activity of Mainolfi Nello

According to the SEC Form 4 filings, Mainolfi Nello, being in a position of

  1. Chief Executive Officer at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 350000 shares for $34.99M,
    over all time since 2021-04-08, has bought 0 shares, and sold 1016000 shares for $65.92M.

Biography of Mainolfi Nello

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $34,989,5737100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
30,000
0.0377%
$113.80$3.41M+0.66%
2026-07-07SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
50,000
0.063%
$119.00$5.95M-4.39%
2026-07-01SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
80,000
0.0982%
$115.29$9.22M-0.15%
2026-04-29SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
30,000
0.0356%
$81.18$2.44M+35.43%
2026-02-25SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
30,000
0.0378%
$90.26$2.71M+16.19%
2025-12-31SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
30,000
0.0417%
$78.06$2.34M+13.78%
2025-12-08SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
100,000
0.1314%
$89.17$8.92M-7.32%
2025-10-29SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
30,000
0.0443%
$60.99$1.83M+42.73%
2025-09-16SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
30,000
0.0421%
$49.00$1.47M+68.66%
2025-06-03SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
30,000
0.0518%
$49.00$1.47M+52.87%
2022-01-12SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
8,612
0.0171%
$52.08$448,551-44.59%
2022-01-11SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
16,923
0.0329%
$54.00$913,795-47.76%
2022-01-10SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
22,465
0.0424%
$53.26$1.2M-48.49%
2021-10-11SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
12,912
0.0274%
$53.69$693,181-31.89%
2021-10-08SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
83,088
0.1767%
$56.76$4.72M-34.78%
2021-08-04SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
2,074
0.004%
$60.03$124,506-31.26%
2021-08-03SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
11,338
0.0116%
$31.07$352,325-29.97%
2021-08-02SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
46,912
0.0936%
$60.30$2.83M-29.27%
2021-07-30SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
12,558
0.0247%
$60.07$754,334-29.68%
2021-07-29SaleKymera Therapeutics, Inc.
KYMR
Chief Executive Officer
1,360
0.0015%
$31.04$42,214-26.07%
Total: 36
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.